Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • The Fine Print
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Health Care

Insights on Health Care

1124 total results. Page 2 of 45.

Filter by Type
    Filter by Industries
      Filter by Practices
        Health Care Counsel Blog
        Federal Court Holds That Pathology Group States Viable Claims Against Multiplan and Cigna for Failing to Ensure In-Network Payment
        March 20, 2025
        Katie Heilman, Pascal Naples

        A federal court recently rejected arguments by MultiPlan, Inc. and Cigna Health and Life Insurance Company that they had no obligation to ensure payments at the contractually negotiated, in-network rate to Anatomic and Clinical Laboratory Associates, P.C. (ACLA).

        Health Care Counsel Blog
        Navigating Pharma Changes in 2025: The Future of Off-Label Promotion
        March 17, 2025
        Stephanie Trunk

        Join AFS Life Sciences Partner Stephanie Trunk and Darshan Kulkarni, Life Sciences regulatory and compliance attorney, as they explore the major shifts occurring in the pharmaceutical industry under the Trump Administration.

        Health Care Counsel Blog
        Implications of New Federal Immigration Policies for Health Care Facilities, Part 2: Patient Privacy Concerns
        March 11, 2025
        Annie Chang Lee, Berin S. Romagnolo, Gayland O. Hethcoat II, Moyosore O. Koya

        On January 20, the US Department of Homeland Security (DHS) rescinded 2021 guidelines that previously designated hospitals, clinics, and other health care facilities as “protected areas” and limited immigration enforcement actions in or near such locations.

        Press Release
        Healthcare Group Purchasing Organizations Continue to Adapt and Innovate in a Changing Healthcare Marketplace
        March 11, 2025

        GPOs seek to promote innovation and cost savings despite large changes in the healthcare supply chain, according to the latest report by industry ethics monitor HGPII.

        Investigations Blog
        FCA Enforcement & Compliance Digest — Winter 2025 False Claims Act Newsletter
        March 10, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Pascal Naples, Meghan F. Hart, Nardeen Billan

        Welcome to the Winter 2025 issue of “FCA Enforcement & Compliance Digest,” our quarterly newsletter in which we compile essential updates on False Claims Act (FCA) enforcement trends, litigation, agency guidance, and compliance tips. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.

        Investigations Blog
        Jury Clears SuperValu of Liability in Whistleblower FCA Prescription Pricing Case
        March 7, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Nardeen Billan, Elizabeth Satarov

        Headlines that Matter for Companies and Executives in Regulated Industries

        Health Care Counsel Blog
        HHS Rescinds Richardson Waiver and Signals Reduced Opportunity for Public Comment on Agency Action
        March 4, 2025
        David S. Greenberg, Emily Cowley Leongini, Moyosore O. Koya, Aida Al-Akhdar

        On March 3, the US Department of Health and Human Services (HHS) published a change in policy that could result in fewer opportunities for stakeholders and members of the public to weigh in on HHS regulatory action related to agency management or personnel, public property, loans, grants, benefits, or contracts.

        Investigations Blog
        Home Health Care Company to Pay $3 Million to Resolve FCA Allegations
        February 28, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Nardeen Billan, Rebekkah R.N. Stoeckler

        Headlines that Matter for Companies and Executives in Regulated Industries

        Events
        2025 Chief of Staff Boot Camp
        February 28, 2025
        Lowell C. Brown, Annie Chang Lee

        Health Care Partners Lowell Brown and Annie Lee and Counsel Sarah Benator will present at The Institute for Medical Leadership’s Chief of Staff Boot Camp in Los Angeles, California.

        Health Care Counsel Blog
        Massachusetts Enacts Drug Pricing Legislation: Introducing PBM Licensure, Mandatory Cost Reporting, and Consumer Cost-Sharing Limits
        February 27, 2025
        Anne M. Murphy, Stephanie Trunk, Aida Al-Akhdar

        On January 8, Massachusetts Governor Maura Healy signed into law “An Act Relative To Pharmaceutical Access, Costs And Transparency.” The Act will have a profound impact on all parties involved in setting and applying drug prices, including Pharmacy Benefit Managers (PBMs), health insurance plans, pharmaceutical manufacturers, and retail pharmacies.

        Events
        Regulatory Issues for Life Sciences Companies in 2025
        February 27, 2025
        Philip S. English*, David R. Hamill, Wayne H. Matelski, Stephanie Trunk, Brian P. Waldman, Joy Marie Virga

        ArentFox Schiff professionals will discuss recent matters that directly impact the life sciences industry and its trajectory.

        Alerts
        FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
        February 26, 2025
        Emily Cowley Leongini, Gayland O. Hethcoat II

        Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes medication.

        Health Care Counsel Blog
        Implications of New Federal Immigration Policies for Health Care Facilities, Part 1: Preparing for an Onsite Enforcement Action
        February 24, 2025
        Annie Chang Lee, Berin S. Romagnolo, Gayland O. Hethcoat II, Moyosore O. Koya

        On January 20, the US Department of Homeland Security (DHS) rescinded 2021 guidelines that prohibited immigration enforcement actions in or near medical and health care facilities and other protected areas. Hospitals and other health care facilities should consider the impact this policy change may have on their workforces and patient populations and develop appropriate protocols for responding to an immigration enforcement action on their premises.

        Investigations Blog
        First Circuit Joins Sixth and Eighth Circuits in Adopting Heightened, But-For Causation Standard for AKS-Based FCA Claims
        February 21, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Pascal Naples, Rebekkah R.N. Stoeckler

        Headlines that Matter for Companies and Executives in Regulated Industries

        Health Care Counsel Blog
        Top Legal Challenges for the Health Care Industry in 2025
        February 20, 2025
        David S. Greenberg, Douglas A. Grimm, Annie Chang Lee, Michele L. Gipp, Anne M. Murphy, Stephanie Trunk, Hillary M. Stemple, Gayland O. Hethcoat II, D. Jacques Smith, Daniel J. McQueen, Jeffrey B. Tate , Brian D. Schneider, Moyosore O. Koya, William R. Mitchell, Rebekkah R.N. Stoeckler, Pascal Naples

        With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

        Health Care Counsel Blog
        The Uncertain Future of Gender-Affirming Care for Minors, Part 1: United States v. Skrmetti
        February 19, 2025
        Gayland O. Hethcoat II, Aida Al-Akhdar

        Gender-affirming care (GAC) is a model of care encompassing medical, surgical, mental health, and non-medical services to support transgender and nonbinary individuals in affirming their gender identity. Advocates argue that GAC can be lifesaving for transgender youth experiencing gender dysphoria, a condition characterized by clinically significant distress resulting from incongruence between one’s gender identity and sex assigned at birth. However, recent legislative, executive, and judicial developments at both the federal and state levels have cast uncertainty over the future of GAC for minors.

        Investigations Blog
        President Trump Puts a “Pause” on FCPA Enforcement
        February 14, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, John M. Hindley, Pascal Naples

        Headlines that Matter for Companies and Executives in Regulated Industries

        Health Care Counsel Blog
        Proposed Changes to the HIPAA Security Rule: What Regulated Entities Need to Know
        February 7, 2025
        Douglas A. Grimm, Gayland O. Hethcoat II

        In the final days of the Biden Administration, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued a notice of proposed rulemaking (NPRM) to modify the Security Rule under the Health Insurance Portability and Accountability Act (HIPAA). The NPRM proposes sweeping changes that impact how health care providers, health plans, and health care clearinghouses (covered entities) and their business associates (collectively, regulated entities) implement, document, and maintain safeguards for electronic protected health information (ePHI). OCR is accepting public comments on the NPRM through March 7.

        Investigations Blog
        Ninth Circuit Reverses Dismissal of FCA Suit
        February 7, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, John M. Hindley, Apeksha Vora

        Headlines that Matter for Companies and Executives in Regulated Industries

        Investigations Blog
        Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million
        January 31, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Roberto Martinez, Apeksha Vora

        Headlines that Matter for Companies and Executives in Regulated Industries

        Health Care Counsel Blog
        California Claps Back on Insurer Use of AI to Deny Needed Medical Care Decisions
        January 30, 2025
        Caroline Turner English, Katie Heilman, David S. Greenberg, Hannah Z. Shlaferman

        California is leading the way in ensuring that determinations of medically necessary health care services are made by licensed physicians and not artificial intelligence (AI) algorithms.

        Trump’s Policy Playbook
        Grimm Quoted on Legal Implications for Hospitals as They Brace for Immigration Agents
        January 28, 2025
        Douglas A. Grimm

        Health Care Practice Leader Douglas A. Grimm was quoted by Law360, urging hospital leaders and lawyers across the country to start implementing new strategies after the Trump Administration pulled back a Biden Administration 2021 directive to avoid immigration enforcement at certain locations, including hospitals.

        Investigations Blog
        Massachusetts District Court Judge Applies Heightened Causation Standard in FCA Case
        January 24, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, M.H. Joshua Chiu, Roberto Martinez

        Headlines that Matter for Companies and Executives in Regulated Industries

        Investigations Blog
        DOJ Reports Nearly $3 Billion in FCA Settlements, Judgments for FY 2024
        January 17, 2025
        D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, M.H. Joshua Chiu

        Headlines that Matter for Companies and Executives in Regulated Industries

        Health Care Counsel Blog
        Health Care Providers Should Seriously Consider Claims Under Two Antitrust Class Actions
        January 14, 2025
        David S. Greenberg, Brian D. Schneider

        Now is the time for health care providers to consider participating in the recent Blue Cross Blue Shield (BCBS) antitrust class action settlement and the newly filed antitrust cases alleging widespread price fixing for out-of-network claims by MultiPlan and health insurers.

        Pagination

        • First page « First
        • Previous page ‹ Previous
        • Page 1
        • Current page 2
        • Page 3
        • Page 4
        • Page 5
        • Page 6
        • Page 7
        • Page 8
        • Page 9
        • …
        • Next page Next ›
        • Last page Last »

        Footer

        • About
          • Leadership
          • Alumni
          • Diversity
          • Pro Bono
        • Careers
          • Attorney Opportunities
          • Professional Opportunities
          • Summer Program
        • Locations
          • Washington, DC
          • Chicago
          • New York
          • Los Angeles
          • Boston
          • San Francisco
          • Lake Forest
          • Ann Arbor
          • Decentraland
        • Contact
          • Subscribe

        Social

        Linkedin Twitter Youtube

        Sub footer

        • Disclaimer
        • Privacy Policy
        • Terms of Use
        • Accessibility
        • Non Discrimination

        © Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

        Back to Top